At a glance
ClinicalIndex Comparison RecordN/ACompleted· 398 enrolled
Drug / intervention
Blazer Open-Irrigated Ablation Catheter (Boston Scientific) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation
In Brief
A clinical study evaluating Blazer Open-Irrigated Ablation Catheter (Boston Scientific) and FDA Approved Open-Irrigated Ablation Catheter for Paroxysmal Atrial Fibrillation (PAF). Completed, enrolled 398 participants across 38 sites in 9 countries.
Detailed Summary
The purpose of this study is to establish the safety and effectiveness of the Blazer Open-Irrigated radiofrequency ablation catheter for the treatment of drug refractory, recurrent, symptomatic, paroxysmal atrial fibrillation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParoxysmal Atrial Fibrillation (PAF)
CountriesAustralia, Czechia, France, Germany, Portugal, Spain, Sweden, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 2012
Enrollment StartOct 2012
Primary CompletionOct 2016
TodayJul 2026
First PostedSep 18, 2012
Enrollment StartOct 1, 2012
Primary CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 13.8 years ago
Interventions
Blazer Open-Irrigated Ablation Catheter (Boston Scientific)device
FDA Approved Open-Irrigated Ablation Catheterdevice